How COVID-19 Is Changing Addiction Medicine: A Summary from the Canadian Society of Addiction Medicine–International Society of Addiction Medicine 2020 Conference
In collaboration with the Canadian Society of Addiction Medicine (CSAM), the Canadian Centre on Substance Use and Addiction sponsored a specialized track on COVID-19 and substance use for the joint
Guidelines for Partnering with People with Lived and Living Experience of Substance Use and Their Families and Friends
People with lived and living experience of substance use and their families and friends (LLEAFF) are experts in the field of substance use.
Alcohol and Cannabis Retail Regulations During the COVID-19 Pandemic in Canada [March 1, 2021]
These policy tracking tables provide details about changes to alcohol and cannabis retail regulations during the pandemic.
Consultation on the Cannabis Regulations: Cannabis Research and Other Regulatory Issues [Policy Brief]
Outlines key considerations submitted to Health Canada’s Consultation on the Cannabis Regulations: Cannabis research and other regulatory issues.
Alcohol and Cannabis Retail Regulations During the COVID-19 Pandemic in Canada [initial lockdown March/April 2020]
These policy tracking tables provide details about regulatory changes to alcohol and cannabis retail during the pandemic.
Maintaining a Public Health Approach to Alcohol Policy During COVID-19 [Policy Brief]
This policy brief identifies ways to address higher-risk alcohol use during the COVID-19 pandemic.
Cannabis Retail During COVID-19 [Policy Brief]
This policy brief provides an overview of cannabis regulatory changes made in response to the COVID-19 pandemic between March and August 2020 and presents preliminary data on changes to cannabis sa
Substance Use Treatment in the Northwest Territories 2016–2017 [infographic]
Illustrates data on substance use treatment in the Northwest Territories in 2016–2017.